BIOTRONIK and the University of Sydney have signed a Memorandum of Understanding (MoU) to jointly advance cardiac care with digital and connected health innovations through 2028.
The organisations say the collaboration aims to co-design solutions that address real-world clinical needs, by combining BIOTRONIK’s expertise in implanted cardiac devices and remote monitoring with the University of Sydney’s world-class research capabilities and the expertise of the Westmead Applied Research Centre (WARC) in patient-facing digital health tools.
“This MoU is about more than just technology. It’s about reimagining how we deliver care,” said Jan Ewert, Managing Director, BIOTRONIK Australia and New Zealand. “We aim to create digital tools that integrate into existing workflows and empower clinicians and patients to improve care provision and outcomes.”
Over the next three years, the partnership will focus on developing and clinically evaluating new tools in areas such as remote patient monitoring, AI, and clinical decision support. These innovations will be tested in real-world settings to ensure they deliver measurable value to both patients and healthcare systems. The initiative hopes to benefit patients particularly in remote or underserved regions with limited access to care.
“We are thrilled to deepen our relationship with BIOTRONIK to co-develop digital health solutions that are grounded in clinical evidence and designed with patient welfare at the heart,” said Professor Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine at the Sydney Medical School. “It presents a unique opportunity to translate cutting-edge research into real-world impact for people living with cardiovascular disease.”
